Mediclin AG
XETRA:MED
Intrinsic Value
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. [ Read More ]
The intrinsic value of one MED stock under the Base Case scenario is 18.52 EUR. Compared to the current market price of 2.9 EUR, Mediclin AG is Undervalued by 84%.
Valuation Backtest
Mediclin AG
Run backtest to discover the historical profit from buying and selling MED stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Mediclin AG
Current Assets | 299.8m |
Cash & Short-Term Investments | 174.4m |
Receivables | 94.3m |
Other Current Assets | 31.2m |
Non-Current Assets | 580.7m |
Long-Term Investments | 66.9k |
PP&E | 514.4m |
Intangibles | 22.8m |
Other Non-Current Assets | 43.4m |
Current Liabilities | 171.2m |
Accounts Payable | 12.6m |
Other Current Liabilities | 158.6m |
Non-Current Liabilities | 513.3m |
Long-Term Debt | 428.9m |
Other Non-Current Liabilities | 84.5m |
Earnings Waterfall
Mediclin AG
Revenue
|
766.7m
EUR
|
Cost of Revenue
|
-137.4m
EUR
|
Gross Profit
|
629.4m
EUR
|
Operating Expenses
|
-610.6m
EUR
|
Operating Income
|
18.7m
EUR
|
Other Expenses
|
-29.5m
EUR
|
Net Income
|
-10.8m
EUR
|
Free Cash Flow Analysis
Mediclin AG
MED Profitability Score
Profitability Due Diligence
Mediclin AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Mediclin AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
MED Solvency Score
Solvency Due Diligence
Mediclin AG's solvency score is 32/100. The higher the solvency score, the more solvent the company is.
Score
Mediclin AG's solvency score is 32/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MED Price Targets Summary
Mediclin AG
According to Wall Street analysts, the average 1-year price target for MED is 4.54 EUR with a low forecast of 3.84 EUR and a high forecast of 5.36 EUR.
Shareholder Return
MED Price
Mediclin AG
Average Annual Return | -10.67% |
Standard Deviation of Annual Returns | 9.34% |
Max Drawdown | -60% |
Market Capitalization | 137.8m EUR |
Shares Outstanding | 47 500 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 7,115 full-time employees. The company went IPO on 2000-12-04. The firm operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).
Contact
IPO
Employees
Officers
The intrinsic value of one MED stock under the Base Case scenario is 18.52 EUR.
Compared to the current market price of 2.9 EUR, Mediclin AG is Undervalued by 84%.